Browsing Tag
CSL
4 posts
CSL wins FDA approval for ANDEMBRY, the first monthly anti-factor XIIa therapy for hereditary angioedema
CSL’s ANDEMBRY gains U.S. FDA approval as the first monthly HAE treatment targeting factor XIIa. Learn how it redefines disease control for patients.
June 17, 2025
These ASX stocks could double in 2025 — And analysts say it’s just the beginning
Explore April 2025’s top-rated ASX stocks with the highest analyst upside. Find out which Strong Buys may be mispriced — and why caution still matters.
April 24, 2025
EC approves CSL and Arcturus Therapeutics’ KOSTAIVE mRNA COVID-19 vaccine
The European Commission (EC) has officially granted COVID-19 vaccine approval for KOSTAIVE, the first self-amplifying mRNA vaccine for…
February 16, 2025
CSL Behring bags Hemgenix EC approval for treatment of Hemophilia B
German-based biotechnology company CSL Behring has received conditional marketing authorization (CMA) from the European Commission (EC) for its…
February 22, 2023